Citations

Mayo Clinic

Showing 10 of 108602 citations.

The future burden of Parkinson's disease
Rocca, Walter A.

Movement Disorders | August 7, 2017 | Volume: 33 | Issue: 1 | Pages: 8-9

10.1002/mds.27114 | PMID 28782890 Get It

The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease
Saffouri, George, Loftus, Edward V. , Pardi, Darrell S. , Khanna, Sahil , Loftus, Edward V , Gupta, Arjun , Baddour, Larry M.

Scandinavian Journal of Gastroenterology | August 7, 2017 | Volume: 52 | Issue: 11 | Pages: 1240-1247

10.1080/00365521.2017.1362466 | PMID 28782372 Get It

Liver transplantation: Rejection and tolerance
Taner, Timuçin

Liver Transplantation | August 5, 2017 | Volume: 23 | Issue: S1 | Pages: S85-S88

10.1002/lt.24840 | PMID 28779559 Get It

Very high‐frequency oscillations: Novel biomarkers of the epileptogenic zone
Brázdil, Milan , Pail, Martin , Halámek, Josef , Plešinger, Filip , Cimbálník, Jan , Román, Róbert , Klimeš, Petr , Daniel, Pavel, Chrastina, Jan , Rektor, Ivan , Jurák, Pavel , Brazdil, Milan , Brichtová, Eva , Worrell, Gregory A. , Klimes, Petr , Daniel, Pavel , Roman, Robert

Annals of Neurology | August 5, 2017 | Volume: 82 | Issue: 2 | Pages: 299-310

10.1002/ana.25006 | PMID 28779553 Get It

ObjectiveIn the present study, we aimed to investigate depth electroencephalographic (EEG) recordings in a large cohort of patients with drug‐resistant epilepsy and to focus on interictal very high‐frequency oscillations (VHFOs) between 500Hz and 2kHz. We hypothesized that interictal VHFOs are more specific biomarkers for epileptogenic zone compared to traditional HFOs.MethodsForty patients with focal epilepsy who underwent presurgical stereo‐EEG (SEEG) were included in the study. SEEG data were recorded with a sampling rate of 25kHz, and a 30‐minute resting period was analyzed for each patient. Ten patients met selected criteria for analyses of correlations with surgical outcome: detection of interictal ripples (Rs), fast ripples (FRs), and VHFOs; resective surgery; and at least 1 year of postoperative follow‐up. Using power envelope computation and visual inspection of power distribution matrixes, electrode contacts with HFOs and VHFOs were detected and analyzed.ResultsInterictal very fast ripples (VFRs; 500–1,000Hz) were detected in 23 of 40 patients and ultrafast ripples (UFRs; 1,000–2,000Hz) in almost half of investigated subjects (n = 19). VFRs and UFRs were observed only in patients with temporal lobe epilepsy and were recorded exclusively from mesiotemporal structures. The UFRs were more spatially restricted in the brain than lower‐frequency HFOs. When compared to R oscillations, significantly better outcomes were observed in patients with a higher percentage of removed contacts containing FRs, VFRs, and UFRs.InterpretationInterictal VHFOs are relatively frequent abnormal phenomena in patients with epilepsy, and appear to be more specific biomarkers for epileptogenic zone when compared to traditional HFOs. Ann Neurol 2017;82:299–310
Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing
Brown, Sherry‐Ann , Jouni, Hayan, Marroush, Tariq S. , Brown, Sherry-Ann N, Kullo, Iftikhar J.

Circulation: Cardiovascular Genetics | August 5, 2017 | Volume: 10 | Issue: 4 | Pages: No page available

10.1161/circgenetics.116.001613 | PMID 28779015 Get It

Background— Whether disclosing genetic risk for coronary heart disease (CHD) to individuals influences information seeking and information sharing is not known. We hypothesized that disclosing genetic risk for CHD to individuals influences information seeking and sharing. Methods and Results— The MI-GENES study (Myocardial Infarction Genes) randomized participants (n=203) aged 45 to 65 years who were at intermediate CHD risk based on conventional risk factors and not on statins to receive their conventional risk score alone or also a genetic risk score based on 28 variants. CHD risk was disclosed by a genetic counselor and then discussed with a physician. Surveys assessing information seeking were completed before and after risk disclosure. Information sharing was assessed post-disclosure. Six-month post-disclosure, genetic risk score participants were more likely than conventional risk score participants to visit a website to learn about CHD (odds ratio [OR], 4.88 [confidence interval (CI), 1.55–19.13]; P =0.01), use the internet for information about how genetic factors affect CHD risk (OR, 2.11 [CI, 1.03–4.47]; P =0.04), access their CHD risk via a patient portal (OR, 2.99 [CI, 1.35–7.04]; P =0.01), and discuss their CHD risk with others (OR, 3.13 [CI, 1.41–7.47]; P =0.01), particularly their siblings (OR, 1.92 [CI, 1.06–3.51]; P =0.03), extended family (OR, 3.8 [CI, 1.37–12.38]; P= 0.01), coworkers (OR, 2.42 [CI, 1.09–5.76]; P =0.03), and primary care provider (PCP; OR, 2.00 [CI, 1.08–3.75]; P =0.03). Conclusions— Disclosure of a genetic risk score for CHD increased information seeking and sharing. Clinical Trial Registration— URL: https://clinicaltrials.gov/ . Unique identifier: NCT01936675.
A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor
McCarville, Justin L. , Dong, Jasmine, Caminero, Alberto , Jury, Jennifer , Duboux, Stéphane , Delley, Michelle, Tangyu, M., Mercenier, Annick , Bergonzelli, Gabriela E. , Verdú, Elena F. , Verdu, Elena F , Bermúdez-Brito, Miriam , Murray, Joseph A. , Steinmann, Maren , Langella, Philippe , Caminero, A

Applied and Environmental Microbiology | August 5, 2017 | Volume: 83 | Issue: 19 | Pages: No page available

10.1128/aem.01323-17 | PMID 28778891 Get It

ABSTRACT Microbiota-modulating strategies, including probiotic administration, have been tested for the treatment of chronic gastrointestinal diseases despite limited information regarding their mechanisms of action. We previously demonstrated that patients with active celiac disease have decreased duodenal expression of elafin, a human serine protease inhibitor, and supplementation of elafin by a recombinant Lactococcus lactis strain prevents gliadin-induced immunopathology in the NOD/DQ8 mouse model of gluten sensitivity. The commensal probiotic strain Bifidobacterium longum NCC2705 produces a serine protease inhibitor (Srp) that exhibits immune-modulating properties. Here, we demonstrate that B. longum NCC2705, but not a srp knockout mutant, attenuates gliadin-induced immunopathology and impacts intestinal microbial composition in NOD/DQ8 mice. Our results highlight the beneficial effects of a serine protease inhibitor produced by commensal B. longum strains. IMPORTANCE Probiotic therapies have been widely used to treat gastrointestinal disorders with variable success and poor mechanistic insight. Delivery of specific anti-inflammatory molecules has been limited to the use of genetically modified organisms, which has raised some public and regulatory concerns. By examining a specific microbial product naturally expressed by a commensal bacterial strain, we provide insight into a mechanistic basis for the use of B. longum NCC2705 to help treat gluten-related disorders.
Muscle strengthening method using electrical stimulation on antagonist muscle
Nishimura, Hisanori, Imaishi, Kisei, Iwasa, Kiyohiko, Hirota, Keisuke , Tagawa, Yoshihiko, Yamamoto, Toshiyasu, Basford, Jeffrey R.

The proceedings of the JSME annual meeting | August 4, 2017 | Volume: 2000.1 | Pages: 363-364

10.1299/jsmemecjo.2000.1.0_363 Get It

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
Alberts, Rudi , Vries, Elisabeth M. G. de, Goode, Elizabeth C. , Jiang, Xiaojun , Sampaziotis, Fotis , Rombouts, Krista , Böttcher, Katrin , Folseraas, Trine , Weismüller, Tobias J. , Alexander, Graeme, Alvaro, Domenico , Bergquist, Annika , Björkström, Niklas K. , Beuers, Ulrich , Boberg, Kirsten Muri , Bowlus, Christopher L. , Bragazzi, Maria Consiglia , Chazouillères, Olivier , Cheung, Angela , Dalekos, Georgios, Eaton, John E. , Eksteen, Bertus , Ellinghaus, David , Färkkilâ, Martti , Festen, Eleonora A. , Floreani, Annarosa , Franceschet, I., Gotthardt, Daniel , Hoek, Bart van , Holm, Kristian , Hov, Johannes R. , Imhann, Floris , Juran, Brian D., Lenzen, Henrike , Marschall, Hanns–Ulrich , Marzioni, Marco , Melum, Espen , Milkiewicz, Piotr , Müller, Tobias , Parés, Albert , Rupp, Christian , Rust, Christian, Sandford, Richard , Schrumpf, Erik, Silverberg, Mark S. , Srivastava, Brijesh, Sterneck, Martina , Teufel, Andreas , Vallier, Ludovic , Verheij, Joanne , Vila, Arnau Vich , Vries, Boudewijn de, Zachou, Kalliopi , Chapman, Roger W. , Manns, Michael P. , Rushbrook, Simon, Anderson, Carl A. , Karlsen, Tom H. , Ponsioen, Cyriel Y. , Weersma, Rinse K. , Eaton, John, Lazaridis, Konstantinos N. , Ellinghaus, David , Bowlus, Christopher L , Marzioni, Marco , Mason, Andrew L. , Wang, Weiwei , Bjornsson, Einar Stefan , Carbone, Marco , Dalekos, Georgios, Hirschfield, Gideon M. , Hohenester, Simon D. , Invernizzi, Pietro , Lieb, Wolfgang , Liu, Jimmy Z. , Schramm, Christoph , Schreiber, Stefan , Pinzani, Massimo , Franke, André , Bergquist, Annika , Milkiewicz, Piotr , Alvaro, Domenico , Hov, Johannes R , Anderson, Carl A

Gut | August 4, 2017 | Volume: 67 | Issue: 8 | Pages: 1517-1524

10.1136/gutjnl-2016-313598 | PMID 28779025 Get It

Objective Primary sclerosing cholangitis (PSC) is a genetically complex, inflammatory bile duct disease of largely unknown aetiology often leading to liver transplantation or death. Little is known about the genetic contribution to the severity and progression of PSC. The aim of this study is to identify genetic variants associated with PSC disease progression and development of complications. Design We collected standardised PSC subphenotypes in a large cohort of 3402 patients with PSC. After quality control, we combined 130 422 single nucleotide polymorphisms of all patients—obtained using the Illumina immunochip—with their disease subphenotypes. Using logistic regression and Cox proportional hazards models, we identified genetic variants associated with binary and time-to-event PSC subphenotypes. Results We identified genetic variant rs853974 to be associated with liver transplant-free survival (p=6.07×10–9). Kaplan-Meier survival analysis showed a 50.9% (95% CI 41.5% to 59.5%) transplant-free survival for homozygous AA allele carriers of rs853974 compared with 72.8% (95% CI 69.6% to 75.7%) for GG carriers at 10 years after PSC diagnosis. For the candidate gene in the region, RSPO3, we demonstrated expression in key liver-resident effector cells, such as human and murine cholangiocytes and human hepatic stellate cells. Conclusion We present a large international PSC cohort, and report genetic loci associated with PSC disease progression. For liver transplant-free survival, we identified a genome-wide significant signal and demonstrated expression of the candidate gene RSPO3 in key liver-resident effector cells. This warrants further assessments of the role of this potential key PSC modifier gene.
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
Bhanji, Rahima A. , Narayanan, Praveena , Watt, Kymberly D. , Malhi, Harmeet , Allen, Alina M.

Hepatology | August 4, 2017 | Volume: 66 | Issue: 6 | Pages: 2055-2065

10.1002/hep.29420 | PMID 28777879 Get It

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Up to one third of individuals with NAFLD will develop nonalcoholic steatohepatitis (NASH), which is associated with progression to cirrhosis and is rapidly becoming the leading indication for liver transplantation. Sarcopenia is defined as a progressive and generalized loss of skeletal muscle mass, strength, and function. It is observed in up to 60% of patients with end‐stage liver disease and portends a poor prognosis. Recent studies have shown that sarcopenia is a novel risk factor for developing NAFLD. Pathophysiological mechanisms relating sarcopenia and NASH may include insulin resistance (IR) and increased inflammation. IR leads to accumulation of triglycerides in both muscle tissue and the liver. It also exacerbates proteolysis and leads to muscle depletion. Chronic inflammation leads to liver injury and progression of fibrosis. The inflammatory milieu also stimulates protein catabolism. Viewing skeletal muscle as an endocrine organ that secretes various salutary myokines may help us understand its role in the development of steatosis. A better understanding of the pathophysiology will aid in developing physical and pharmacological therapeutic interventions. In this review, we will explore the complex inter‐relationships between sarcopenia and NASH. We will discuss the impact of sarcopenia in patients with NASH and therapeutic options for the management of sarcopenia. (Hepatology 2017;66:2055–2065)
Ablation of Musculoskeletal Metastases
Callstrom, Matthew R. , Kurup, A. Nicholas , Morris, Jonathan M.

American Journal of Roentgenology | August 4, 2017 | Volume: 209 | Issue: 4 | Pages: 713-721

10.2214/ajr.17.18527 | PMID 28777648 Get It